ENALAPRIL Side Effects

7007080-8 | Dizziness, Hypoglycaemia
on Sep 14, 2010 Male patient from GERMANY , 71 years of age, weighting 187.4 lb, was diagnosed with hypertension, diabetes mellitus, restlessness, back pain (What is back pain?) and was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypoglycaemia. Enalapril dosage: . During the same period patient was treated with INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), OPIPRAMOL (View Opipramol Review and Opipramol Label ), TARGIN(OXYCODON HCL W/NALOXON) (20mg Oxycodone+20 Mg Naloxone) (View Targin(oxycodon-hcl W/naloxon) Review and Targin(oxycodon-hcl W/naloxon) Label ). Patient was hospitalized.

6987237-2 | Hypoglycaemia
Patient was taking Enalapril (View Usage). Patient had the following side effects: hypoglycaemia on Sep 02, 2010 from GERMANY Additional patient health information: Female patient , 80 years of age, weighting 200.6 lb, was diagnosed with hypertension, type 2 diabetes mellitus, heart valve incompetence, osteoporosis prophylaxis, hypothyroidism, prophylaxis against gastrointestinal ulcer, chronic obstructive pulmonary disease and. Enalapril dosage: 10 Mg, Bid. During the same period patient was treated with CARVEDILOL (12.5 Mg, Bid) (View Carvedilol Review and Carvedilol Label ), LANTUS (36 Iu, Qd) (View Lantus Review and Lantus Label ), ACTRAPID PENFILL (Unk) (View Actrapid Penfill Review and Actrapid Penfill Label ), ACETYLSALICYLIC ACID (100 Mg, Qd) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CALCIMAGON (1 Df, Bid) (View Calcimagon Review and Calcimagon Label ), LEVOTHYROXINE SODIUM (75 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), OMEPRAZOLE (20 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), PARACODIN BITARTRATE TAB (30 Gtt, Unk) (View Paracodin Bitartrate Tab Review and Paracodin Bitartrate Tab Label ). Patient was hospitalized.

6969882-3 | Hypoglycaemia
Adverse event was reported on Aug 25, 2010 by a Male patient taking Enalapril (View Usage) (Dosage: 5 Mg, Bid) was diagnosed with renal failure, hypertension, type 2 diabetes mellitus, hyperuricaemia, hyperlipidaemia and. Location: GERMANY , 74 years of age, weighting 275.6 lb, After Enalapril was administered, patient had the following side effects: hypoglycaemia. During the same period patient was treated with BISOPROLOL FUMARATE (5 Mg, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ACTRAPHANE HM (45 Iu, Bid) (View Actraphane Hm Review and Actraphane Hm Label ), ALLOPURINOL (300 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), FUROSEMIDE (20 Mg, Bid) (View Furosemide Review and Furosemide Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), XIPAMIDE (20 Mg, Qd) (View Xipamide Review and Xipamide Label ). Patient was hospitalized.

6959389-1 | Angioedema
on Aug 31, 2010 Male patient from UNITED STATES , 65 years of age, weighting 174.2 lb, was diagnosed with hypertension and was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema. Enalapril dosage: 10 Mg Every Day Po. Patient was hospitalized.


6927587-9 | Hyperglycaemia
on Aug 03, 2010 Male patient from GERMANY , 45 years of age, weighting 165.3 lb, was diagnosed with hypertension and was treated with Enalapril (View Usage). Patient had the following side effects: hyperglycaemia. Enalapril dosage: 10 Mg, Qd. During the same period patient was treated with ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (1 Df, Qd) (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ). Patient was hospitalized.

6924999-4 | Lichen Planus
Patient was taking Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: lichen planus on Aug 04, 2010 from GEORGIA Additional patient health information: Female patient , 51 years of age, was diagnosed with hypertension, immune system disorder and. Enalapril dosage: . During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SALAZOPYRINE (View Salazopyrine Review and Salazopyrine Label ), INFLIXIMAB (5 Mg/kg) (View Infliximab Review and Infliximab Label ).

6741241-8 | Renal Artery Stenosis, Renal Failure Acute
Adverse event was reported on May 17, 2010 by a Female patient taking Enalapril (View Usage) (Dosage: Df) was diagnosed with hypertension and. Location: UNITED STATES , child 9 years of age, Patient experienced the following unwanted or unexpected effects: renal artery stenosis, renal failure acute.

6571396-X | Hypoglycaemia
on Jan 27, 2010 Female patient from GERMANY , 85 years of age, weighting 154.3 lb, was diagnosed with cardiac failure, type 2 diabetes mellitus, hyperuricaemia, hypothyroidism, prophylaxis against gastrointestinal ulcer and was treated with Enalapril (View Usage). Patient had the following side effects: hypoglycaemia. Enalapril dosage: 2.5 Mg, Bid. During the same period patient was treated with CARVEDILOL (6.25 Mg, Bid) (View Carvedilol Review and Carvedilol Label ), LANTUS (16 Iu, Qd) (View Lantus Review and Lantus Label ), NOVOMIX (Unk) (View Novomix Review and Novomix Label ), NOVONORM (2 Mg, Tid) (View Novonorm Review and Novonorm Label ), ALLOPURINOL (100 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), DIGITOXIN INJ (0.07 Mg, Qd) (View Digitoxin Inj Review and Digitoxin Inj Label ), LEVOTHYROXINE SODIUM (125 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), OMEPRAZOLE (20 Mg, Bid) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6493438-2 | Pancreatitis Necrotising
on Dec 04, 2009 Female patient from GERMANY , 50 years of age, was diagnosed with hypertension and was treated with Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: pancreatitis necrotising. Enalapril dosage: . Patient was hospitalized.

6438356-0 | Blood Creatinine Increased, Dehydration, Hypotension, Renal Failure Acute
Patient was taking Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, dehydration, hypotension, renal failure acute on Oct 29, 2009 from GERMANY Additional patient health information: Female patient , 71 years of age, weighting 149.9 lb, was diagnosed with hypertension, cardiac failure, hypothyroidism, ischaemic heart disease prophylaxis, type 2 diabetes mellitus and. Enalapril dosage: . During the same period patient was treated with FURESIS (View Furesis Review and Furesis Label ), MICARDIS (View Micardis Review and Micardis Label ), DOPEGYT (View Dopegyt Review and Dopegyt Label ), DIGITOXIN INJ (View Digitoxin Inj Review and Digitoxin Inj Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACTRAPID (Dosis/applikation: 4-0-4 Iu) (View Actrapid Review and Actrapid Label ). Patient was hospitalized.

6429655-7 | Blood Creatinine Increased, Dehydration, Hypotension, Renal Failure Acute
Adverse event was reported on Oct 29, 2009 by a Female patient taking Enalapril (View Usage) (Dosage: 5 Mg, Qd) was diagnosed with hypertension, type 2 diabetes mellitus, ischaemic heart disease prophylaxis, cardiac failure, hypothyroidism and. Location: GERMANY , 71 years of age, weighting 149.9 lb, Patient had the following side effects: blood creatinine increased, dehydration, hypotension, renal failure acute. During the same period patient was treated with FURESIS (40 Mg, Qd) (View Furesis Review and Furesis Label ), DOPEGYT (250 Mg, Bid) (View Dopegyt Review and Dopegyt Label ), MICARDIS (80 Mg, Qd) (View Micardis Review and Micardis Label ), ACTRAPID (Unk) (View Actrapid Review and Actrapid Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), DIGITOXIN TAB (0.07 Mg, Qd) (View Digitoxin Tab Review and Digitoxin Tab Label ), LEVOTHYROXINE SODIUM (175 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6426905-8 | Intentional Overdose
on Oct 26, 2009 Female patient from UNITED STATES , 43 years of age, was treated with Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: intentional overdose. Enalapril dosage: . During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), PROPOXYPHENE HCL AND ACETOMINOPHEN (View Propoxyphene Hcl And Acetominophen Review and Propoxyphene Hcl And Acetominophen Label ), SOMA (View Soma Review and Soma Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6426088-4 | Cough
on Nov 03, 2009 Female patient from UNITED STATES , 77 years of age, weighting 191.0 lb, was diagnosed with hypertension and was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: cough. Enalapril dosage: .05 Mg Daily Po.

6416820-8 | Angioedema, Grand Mal Convulsion
Patient was taking Enalapril (View Usage). Patient had the following side effects: angioedema, grand mal convulsion on Oct 13, 2009 from SOUTH AFRICA Additional patient health information: Female patient , 28 years of age, was diagnosed with hypertension, systemic lupus erythematosus and. Enalapril dosage: 10mg Every 12 Hours. During the same period patient was treated with PREDNISONE TAB (60mg Daily) (View Prednisone Tab Review and Prednisone Tab Label ), ATENOLOL (50mg Daily) (View Atenolol Review and Atenolol Label ), AMLODIPINE (10mg Daily) (View Amlodipine Review and Amlodipine Label ), FUROSEMIDE (40mg Daily) (View Furosemide Review and Furosemide Label ), SIMVASTATIN (10mg Daily) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6230236-9 | Gynaecomastia
Adverse event was reported on Jun 02, 2009 by a Male patient taking Enalapril (View Usage) (Dosage: Daily Dose: 40 Mg Millgram(s) Every Day) was diagnosed with hypertension, hyperlipidaemia and. Location: GERMANY , 77 years of age, weighting 169.8 lb, After Enalapril was administered, patient had the following side effects: gynaecomastia. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Daily Dose: 1 Df Dosage Form Every Day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VERAPAMIL (Daily Dose: 360 Mg Millgram(s) Every Day) (View Verapamil Review and Verapamil Label ), SIMVASTAD (View Simvastad Review and Simvastad Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ).

6163048-5 | Renal Failure Acute
on Apr 09, 2009 Male patient from GERMANY , 80 years of age, weighting 176.4 lb, was diagnosed with hypertension, osteolysis, atrial fibrillation (What is atrial fibrillation?), parkinson's disease (What is parkinson's disease?), hyperprolactinaemia and was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Enalapril dosage: Unk. During the same period patient was treated with ARCOXIA (90 Mg, Qd) (View Arcoxia Review and Arcoxia Label ), TRIAMTEREN (Unk) (View Triamteren Review and Triamteren Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), FALITHROM ^HEXAL^ (Unk) (View Falithrom ^hexal^ Review and Falithrom ^hexal^ Label ), ISOSORBIDE DINITRATE (Unk) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), PK MERZ (View Pk-merz Review and Pk-merz Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6153830-2 | Hypoglycaemia
on Apr 01, 2009 Male patient from GERMANY , 83 years of age, weighting 149.9 lb, was diagnosed with hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, renal failure, asthma (What is asthma?), atrial fibrillation (What is atrial fibrillation?), coronary artery disease (What is coronary artery disease?), ischaemic heart disease prophylaxis and was treated with Enalapril (View Usage). Patient had the following side effects: hypoglycaemia. Enalapril dosage: 10 Mg, Bid. During the same period patient was treated with PROTAPHANE MC (20 Iu, Qd) (View Protaphane Mc Review and Protaphane Mc Label ), INSULIN ACTRAPID HUMAN (Unk) (View Insulin Actrapid Human Review and Insulin Actrapid Human Label ), ACETYLCYSTEINE (600 Mg, Qd) (View Acetylcysteine Review and Acetylcysteine Label ), ALLOPURINOL (100 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), BEROTEC (100 Ug, Qd) (View Berotec Review and Berotec Label ), DIGITOXIN TAB (0.07 Mg, Unk) (View Digitoxin Tab Review and Digitoxin Tab Label ), FALICARD ^ASTA MEDICA^ (40 Mg, Qd) (View Falicard ^asta Medica^ Review and Falicard ^asta Medica^ Label ), FALITHROM ^HEXAL^ (View Falithrom ^hexal^ Review and Falithrom ^hexal^ Label ). Patient was hospitalized.

6146139-4 | Hypoglycaemia
Patient was taking Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: hypoglycaemia on Apr 01, 2009 from GERMANY Additional patient health information: Male patient , 83 years of age, was diagnosed with hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, renal failure, asthma (What is asthma?), atrial fibrillation (What is atrial fibrillation?), coronary artery disease (What is coronary artery disease?), myocardial infarction and. Enalapril dosage: . During the same period patient was treated with INSULIN HUMAN (22-10-20 Iu) (View Insulin Human Review and Insulin Human Label ), ISOPHANE INSULIN (View Isophane Insulin Review and Isophane Insulin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FENOTEROL HYDROBROMIDE (View Fenoterol Hydrobromide Review and Fenoterol Hydrobromide Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ). Patient was hospitalized.

6140546-1 | Hypoglycaemia
Adverse event was reported on Mar 24, 2009 by a Female patient taking Enalapril (View Usage) (Dosage: 2.5 Mg, Bid) was diagnosed with cardiac failure, type 2 diabetes mellitus, hyperuricaemia, hypothyroidism, prophylaxis against gastrointestinal ulcer and. Location: GERMANY , 85 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: hypoglycaemia. During the same period patient was treated with CARVEDILOL (6.25 Mg, Bid) (View Carvedilol Review and Carvedilol Label ), LANTUS (16 Iu, Qd) (View Lantus Review and Lantus Label ), NOVOLOG MIX 70/30 (Unk) (View Novolog Mix 70/30 Review and Novolog Mix 70/30 Label ), REPAGLINIDE (2 Mg, Tid) (View Repaglinide Review and Repaglinide Label ), ALLOPURINOL (100 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), DIGITOXIN (0.07 Mg, Qd) (View Digitoxin Review and Digitoxin Label ), LEVOTHYROXINE SODIUM (125 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), OMEPRAZOLE (20 Mg, Bid) (View Omeprazole Review and Omeprazole Label ).

6128895-4 | Anxiety Disorder, Dyspnoea
on Mar 04, 2009 Female patient from UNITED STATES , weighting 453.0 lb, was diagnosed with hypertension, obesity (What is obesity?) and was treated with Enalapril (View Usage). Patient had the following side effects: anxiety disorder, dyspnoea. Enalapril dosage: 20 Mg Bid Oral. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg Qd Oral) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FELODIPINE (5 Mg Bid Oral) (View Felodipine Review and Felodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), COD LIVER OIL (View Cod-liver Oil Review and Cod-liver Oil Label ), GERITOL /00543501/ (View Geritol /00543501/ Review and Geritol /00543501/ Label ). Patient was hospitalized.

6114369-3 | Hypoglycaemia
on Mar 02, 2009 Male patient from GERMANY , 83 years of age, was treated with Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: hypoglycaemia. Enalapril dosage: 10 Mg, Bid. During the same period patient was treated with PROTAPHANE MC (20 Iu, Qd) (View Protaphane Mc Review and Protaphane Mc Label ), INSULIN ACTRAPID HUMAN (View Insulin Actrapid Human Review and Insulin Actrapid Human Label ), ACETYLCYSTEINE (600 Mg, Qd) (View Acetylcysteine Review and Acetylcysteine Label ), ALLOPURINOL (100 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), BEROTEC (100 Ug, Qd) (View Berotec Review and Berotec Label ), DIGITOXIN TAB (0.07 Mg, Unk) (View Digitoxin Tab Review and Digitoxin Tab Label ), FALICARD ^ASTA MEDICA^ (40 Mg, Qd) (View Falicard ^asta Medica^ Review and Falicard ^asta Medica^ Label ), FALITHROM ^HEXAL^ (View Falithrom ^hexal^ Review and Falithrom ^hexal^ Label ). Patient was hospitalized.

6112288-X | Hypoglycaemia
Patient was taking Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia on Mar 02, 2009 from GERMANY Additional patient health information: Male patient , 83 years of age, . Enalapril dosage: 10 Mg, Bid. During the same period patient was treated with PROTAPHANE MC (20 Iu, Qd) (View Protaphane Mc Review and Protaphane Mc Label ), INSULIN ACTRAPID HUMAN (View Insulin Actrapid Human Review and Insulin Actrapid Human Label ), ACETYLCYSTEINE (600 Mg, Qd) (View Acetylcysteine Review and Acetylcysteine Label ), ALLOPURINOL (100 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), BEROTEC (100 Ug, Qd) (View Berotec Review and Berotec Label ), DIGITOXIN (0.07 Mg, Unk) (View Digitoxin Review and Digitoxin Label ), FALICARD ^ASTA MEDICA^ (40 Mg, Qd) (View Falicard ^asta Medica^ Review and Falicard ^asta Medica^ Label ), FALITHROM ^HEXAL^ (View Falithrom ^hexal^ Review and Falithrom ^hexal^ Label ). Patient was hospitalized.

6112287-8 | Renal Failure Acute
Adverse event was reported on Mar 02, 2009 by a Male patient taking Enalapril (View Usage) (Dosage: 5 Mg, Bid) was diagnosed with hypertension, urinary tract infection (What is urinary tract infection?), cardiac failure, coronary artery disease (What is coronary artery disease?), pain (What is pain?) and. Location: GERMANY , 86 years of age, weighting 143.3 lb, Patient had the following side effects: renal failure acute. During the same period patient was treated with AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (2.5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), LEVOFLOXACIN (250 Mg, Qd) (View Levofloxacin Review and Levofloxacin Label ), XIPAMIDE (20 Mg, Qd) (View Xipamide Review and Xipamide Label ), ASPIRIN (300 Mg, Qd) (View Aspirin Review and Aspirin Label ), CETIRIZINE (10 Mg, Qd) (View Cetirizine Review and Cetirizine Label ), NOVALGIN (30 Gtt, Tid) (View Novalgin Review and Novalgin Label ). Patient was hospitalized.

6112283-0 | Hypoglycaemia
on Mar 02, 2009 Male patient from GERMANY , 74 years of age, weighting 275.6 lb, was diagnosed with renal failure, hypertension, type 2 diabetes mellitus, hyperuricaemia, hyperlipidaemia and was treated with Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: hypoglycaemia. Enalapril dosage: 5 Mg, Bid. During the same period patient was treated with BISOPROLOL (5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), ACTRAPHANE HM (45 Iu, Bid) (View Actraphane Hm Review and Actraphane Hm Label ), ALLOPURINOL (300 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), FUROSEMIDE (20 Mg, Bid) (View Furosemide Review and Furosemide Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), XIPAMIDE (20 Mg, Qd) (View Xipamide Review and Xipamide Label ).

6109528-X | Hypoglycaemia
on Feb 26, 2009 Male patient from GERMANY , 83 years of age, was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Enalapril dosage: . During the same period patient was treated with INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ), ISOPHANE INSULIN (View Isophane Insulin Review and Isophane Insulin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FENOTEROL HYDROBROMIDE (View Fenoterol Hydrobromide Review and Fenoterol Hydrobromide Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ). Patient was hospitalized.

5888364-3 | Angioedema
Patient was taking Enalapril (View Usage). Patient had the following side effects: angioedema on Sep 10, 2008 from NETHERLANDS Additional patient health information: Male patient , weighting 163.1 lb, was diagnosed with hypertension and. Enalapril dosage: . During the same period patient was treated with DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ).

5726706-X | Acute Hepatic Failure
Adverse event was reported on Apr 21, 2008 by a Female patient taking Enalapril (View Usage) (Dosage: Unk) was diagnosed with coronary angioplasty, stent placement and. Location: GERMANY , 65 years of age, After Enalapril was administered, patient had the following side effects: acute hepatic failure. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (Unk) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ISCOVER, PLAVIX (View Iscover, Plavix Review and Iscover, Plavix Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ).

5721395-2 | Acute Hepatic Failure
on Apr 21, 2008 Female patient from GERMANY , 65 years of age, was diagnosed with coronary angioplasty, stent placement and was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure. Enalapril dosage: Unk. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (Unk) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PLAVIX (View Plavix Review and Plavix Label ), ISCOVER, PLAVIX (View Iscover, Plavix Review and Iscover, Plavix Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ).

5715656-0 | Angioedema, Dysphagia
on Apr 23, 2008 Male patient from UNITED STATES , 57 years of age, was treated with Enalapril (View Usage). Patient had the following side effects: angioedema, dysphagia. Enalapril dosage: 10 Mg Every Day Po. Patient was hospitalized.

5609125-6 | Pancytopenia
Patient was taking Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: pancytopenia on Jan 16, 2008 from SPAIN Additional patient health information: Male patient , 72 years of age, was diagnosed with type 2 diabetes mellitus and. Enalapril dosage: . During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ).

5570331-0 | Cerebrovascular Accident, Hemiplegia, Speech Disorder
Adverse event was reported on Dec 10, 2007 by a Male patient taking Enalapril (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: , 84 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, hemiplegia, speech disorder. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DIOVAN HCT (160 Mg, Qd) (View Diovan Hct Review and Diovan Hct Label ). Patient was hospitalized.

5422145-X | Albumin Urine Present, Blood Lactate Dehydrogenase Increased, Brain Herniation, Bronchopneumonia, Cerebral Infarction, Confusional State, Eye Pain, Grimacing
on Aug 06, 2007 Male patient from UNITED KINGDOM , 32 years of age, was diagnosed with hypertension and was treated with Enalapril (View Usage). Patient had the following side effects: albumin urine present, blood lactate dehydrogenase increased, brain herniation, bronchopneumonia, cerebral infarction, confusional state, eye pain, grimacing. Enalapril dosage: Oral.

5293192-6 | Dehydration, Electrocardiogram Abnormal, Heart Rate Decreased, Hyperkalaemia, Renal Failure, Syncope
on Mar 20, 2007 Male patient from GERMANY , 76 years of age, was treated with Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: dehydration, electrocardiogram abnormal, heart rate decreased, hyperkalaemia, renal failure, syncope. Enalapril dosage: Df,. During the same period patient was treated with SPIRONOLACTONE (Df;) (View Spironolactone Review and Spironolactone Label ), TORSEMIDE (Df;) (View Torsemide Review and Torsemide Label ), BETA BLOCKER (View Beta Blocker Review and Beta Blocker Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5114570-1 | Aortic Thrombosis, Cerebral Infarction
Patient was taking Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: aortic thrombosis, cerebral infarction on Sep 04, 2006 from CHILE Additional patient health information: Female patient , 50 years of age, was diagnosed with hypertension, irritable bowel syndrome (What is irritable bowel syndrome?) and. Enalapril dosage: . During the same period patient was treated with ZELMAC / HTF 919A (6 Mg, Qd) (View Zelmac / Htf 919a Review and Zelmac / Htf 919a Label ). Patient was hospitalized.

5103593-4 | Cerebral Infarction
Adverse event was reported on Sep 04, 2006 by a Female patient taking Enalapril (View Usage) (Dosage: ) was diagnosed with hypertension, pain (What is pain?) and. Location: CHILE , 50 years of age, Patient had the following side effects: cerebral infarction. During the same period patient was treated with ZELMAC / HTF 919A (6 Mg, Qd) (View Zelmac / Htf 919a Review and Zelmac / Htf 919a Label ). Patient was hospitalized.

5079562-X | Angioneurotic Oedema, Respiratory Failure
on Aug 11, 2006 Male patient from UNITED STATES , weighting 374.6 lb, was treated with Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: angioneurotic oedema, respiratory failure. Enalapril dosage: 10mg Bid Po. During the same period patient was treated with VALSARTAN (160mg Bid Po) (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

5035114-9 | Angioneurotic Oedema, Swelling Face
on Jun 22, 2006 Female patient from UNITED STATES , 87 years of age, weighting 209.0 lb, was diagnosed with hypertension and was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: angioneurotic oedema, swelling face. Enalapril dosage: Daily Po. Patient was hospitalized.

4998471-5 | Blood Uric Acid Increased, Dermatitis Exfoliative, Hyperkeratosis, Nail Disorder, Nail Pitting, Psoriasis, Psoriatic Arthropathy, Red Blood Cell Sedimentation Rate Increased, Skin Fissures
Patient was taking Enalapril (View Usage). Patient had the following side effects: blood uric acid increased, dermatitis exfoliative, hyperkeratosis, nail disorder, nail pitting, psoriasis, psoriatic arthropathy, red blood cell sedimentation rate increased, skin fissures on Apr 20, 2006 from BULGARIA Additional patient health information: Male patient , 59 years of age, was diagnosed with hypertension and. Enalapril dosage: 10 Mg Bid. Patient was hospitalized.

4906145-1 | Renal Failure Acute
Adverse event was reported on Feb 07, 2006 by a Male patient taking Enalapril (View Usage) (Dosage: 10 Mg Daily) was diagnosed with diabetes mellitus, hypertension and. Location: UNITED STATES , 78 years of age, weighting 188.0 lb, After Enalapril was administered, patient had the following side effects: renal failure acute. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACCU CHEK COMFORT CV (View Accu-chek Comfort Cv Review and Accu-chek Comfort Cv Label ), PSYLLIUM (View Psyllium Review and Psyllium Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ). Patient was hospitalized.

4906070-6 | Gastrointestinal Disorder, Laboratory Test Abnormal, Pancreatitis
on Feb 07, 2006 Male patient from UNITED STATES , 39 years of age, weighting 200.0 lb, was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder, laboratory test abnormal, pancreatitis. Enalapril dosage: 10 Mg Daily. Patient was hospitalized.

4903501-2 | Hypersensitivity, Swelling Face
on Feb 06, 2006 Male patient from UNITED STATES , 60 years of age, was diagnosed with cardiac failure congestive, hypertension and was treated with Enalapril (View Usage). Patient had the following side effects: hypersensitivity, swelling face. Enalapril dosage: 20 Mg Bid. Patient was hospitalized.

4903345-1 | Dysphagia, Dyspnoea, Epiglottic Oedema, Palatal Oedema
Patient was taking Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: dysphagia, dyspnoea, epiglottic oedema, palatal oedema on Feb 06, 2006 from UNITED STATES Additional patient health information: Male patient , 55 years of age, was diagnosed with hypertension and. Enalapril dosage: 20mg Bid.

4894770-6 | Acute Myocardial Infarction, Cardiac Aneurysm
Adverse event was reported on Oct 17, 2005 by a Male patient taking Enalapril (View Usage) (Dosage: 10 Mg, Qd) was diagnosed with hypertension, colitis ulcerative, coronary artery disease (What is coronary artery disease?), insulin-requiring type ii diabetes mellitus and. Location: , 72 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, cardiac aneurysm. During the same period patient was treated with SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), NOVOLOG MIX 70/30 (44 Iu, Qd) (View Novolog Mix 70/30 Review and Novolog Mix 70/30 Label ), ISOSORBIDE MONONITRATE (40 Mg, Qd) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), SIMVASTATIN (40 Mg, Unk) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

4892230-X | Angioneurotic Oedema
on Jan 25, 2006 Female patient from UNITED STATES , 73 years of age, weighting 176.4 lb, was diagnosed with hypertension and was treated with Enalapril (View Usage). Patient had the following side effects: angioneurotic oedema. Enalapril dosage: 1.25mg Iv Q6hr. Patient was hospitalized.

4890042-4 | Atrial Fibrillation, Blood Bicarbonate Decreased, Blood Creatinine Increased, Blood Glucose Increased, Blood Ph Decreased, Blood Pressure Decreased, Blood Urea Increased, Bradycardia, Cardiac Murmur
on Jan 04, 2006 Female patient from GREECE , 78 years of age, was diagnosed with tachycardia and was treated with Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood bicarbonate decreased, blood creatinine increased, blood glucose increased, blood ph decreased, blood pressure decreased, blood urea increased, bradycardia, cardiac murmur. Enalapril dosage: 20 Mg Q Day. During the same period patient was treated with AMILORIDE HCL (5 Mg Q Day) (View Amiloride Hcl Review and Amiloride Hcl Label ), SPIRONOLACTONE (50 Mg Q Day) (View Spironolactone Review and Spironolactone Label ), DIGOXIN (0.25 Mg Q Day) (View Digoxin Review and Digoxin Label ), PROCAINAMIDE (200 Mg Iv) (View Procainamide Review and Procainamide Label ), LIDOCAINE (100 Mg Iv) (View Lidocaine Review and Lidocaine Label ). Patient was hospitalized.

4889399-X | Hepatitis Toxic, Jaundice, Liver Disorder, Transaminases Increased
Patient was taking Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis toxic, jaundice (What is jaundice?), liver disorder, transaminases increased on Sep 13, 2005 from GERMANY Additional patient health information: Female patient , 65 years of age, was diagnosed with hypertonic bladder, back pain (What is back pain?), eye operation and. Enalapril dosage: . During the same period patient was treated with DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), EMSELEX EXTENDED RELEASE (7.5 Mg Daily) (View Emselex Extended Release Review and Emselex Extended Release Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ANAESTHETICS (View Anaesthetics Review and Anaesthetics Label ). Patient was hospitalized.

4846241-0 | Angioneurotic Oedema, Dyspnoea
Adverse event was reported on Dec 02, 2005 by a Female patient taking Enalapril (View Usage) (Dosage: ) . Location: UNITED STATES , 63 years of age, Patient had the following side effects: angioneurotic oedema, dyspnoea. Patient was hospitalized.

4809869-X | Haemodialysis, Renal Failure Acute
on Oct 24, 2005 Female patient from UNITED STATES , 69 years of age, was treated with Enalapril (View Usage). After Enalapril was administered, patient had the following side effects: haemodialysis, renal failure acute. Enalapril dosage: 5mg Po Bid. During the same period patient was treated with SULINDAC (200mg Po Bid) (View Sulindac Review and Sulindac Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ALENDRONATE (View Alendronate Review and Alendronate Label ), ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), ESTROGEN VAGINAL CREAM (View Estrogen Vaginal Cream Review and Estrogen Vaginal Cream Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

4806902-6 | Hyperkalaemia
on Oct 20, 2005 Male patient from UNITED STATES , 75 years of age, weighting 116.4 lb, was treated with Enalapril (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia. Enalapril dosage: . During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), PRAZOSIN HCL (View Prazosin Hcl Review and Prazosin Hcl Label ), TRIAMCINOLONE ACETONIDE (View Triamcinolone Acetonide Review and Triamcinolone Acetonide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DM 10/GUAIFENESN 100MG/5ML (ALC F/SF) (View Dm 10/guaifenesn 100mg/5ml (alc-f/sf) Review and Dm 10/guaifenesn 100mg/5ml (alc-f/sf) Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SODIUM POLYSTYRENE SULFONATE SUSP (View Sodium Polystyrene Sulfonate Susp Review and Sodium Polystyrene Sulfonate Susp Label ). Patient was hospitalized.

4786234-5 | Completed Suicide, Intentional Misuse, Overdose
Patient was taking Enalapril (View Usage). Patient had the following side effects: completed suicide, intentional misuse, overdose on Sep 13, 2005 from UNITED STATES Additional patient health information: Female patient , 15 years of age, . Enalapril dosage: Df, Po. During the same period patient was treated with METFORMIN (Df, Po) (View Metformin Review and Metformin Label ), DIPHENHYDRAMINE (Df , Po) (View Diphenhydramine Review and Diphenhydramine Label ).